Zanamivir Suppliers & Bulk Manufacturers
Available Forms: Inhalation powder
Available Strengths: 5 mg/blister
Reference Brands: Relenza(EU & US)
Category: Anti Viral
Zanamivir (Relenza) is an inhaled antiviral used to treat and prevent Influenza A and B. It’s effective when used early and is approved for adults and children via a Diskhaler device. Zanamivir is available in Inhalation powder and strengths such as 5 mg/blister. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Zanamivir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Zanamivir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Zanamivir, marketed under the brand name Relenza, is an FDA- and EMA-approved antiviral drug used for the treatment and prevention of Influenza A and B. As a neuraminidase inhibitor, Zanamivir prevents the release of new virus particles from infected cells, reducing flu severity and duration when started within 48 hours of symptoms. It is administered via oral inhalation using a Diskhaler, with each dose delivering 10 mg (two 5 mg blisters). Zanamivir is approved for use in adults and children (≥7 years for treatment, ≥5 for prevention). Relenza offers a localized delivery option with minimal systemic side effects.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Zanamivir is used to treat and prevent influenza A and B infections. It works by inhibiting the viral neuraminidase enzyme, which stops the release of new virus particles from infected cells, helping reduce the severity and duration of flu symptoms when taken early.
Zanamivir is a synthetic neuraminidase inhibitor derived from sialic acid analogues. Its structure is designed to bind tightly to the active site of the neuraminidase enzyme, blocking viral replication.
The most well-known trade name for Zanamivir is Relenza.
Relenza is manufactured by GlaxoSmithKline (GSK).
The generic name of the product is zanamivir.
The commonly known brand name is Relenza.
Zanamivir (Relenza) is manufactured by GlaxoSmithKline in its approved global production facilities, with distribution depending on regional regulatory approvals.
Related Products
Maraviroc
Strength:
150 mg, 300 mg, 20 mg
Form: Tablets / Oral solution
Reference Brands: Selzentry (USA), Celsentri (EU)
View Details
Raltegravir
Strength:
100mg, 400 mg, 600mg
Form: Tablets
Reference Brands: Isentress (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
